proteus digital health device allows people track medication injection sand grain sized ingestible tracker built pill patient wears sensor patch monitors ingestion physiologic response heart rate change etc patient permission information communicated physician technology around years fact half patients take medications wrong new proteus applying fda approval use sensor abilify psychiatric medication news release today patients suffering severe mental illnesses struggle adhering communicating healthcare teams medication regimen greatly impact outcomes disease progression said william carson president ceo otsuka pharmaceutical development commercialization inc believe new digital medicine could revolutionize way adherence measured fulfill serious unmet medical need population look forward continuing working fda throughout nda review think want know patient taking every dose medication patients want docs follow closely i ask worried privacy issues really medical privacy left worry psychotropic medications concerned whether patients taking medications diabetes congestive heart failure perhaps could track people take antibiotics lyme disease see follow antibiotic regimen exactly better outcome people like technology roy would probably stick little sensor things flintstone vitamins could clinkshrink would monitor ice cream consumption physiologic responses pupils get much bigger eats chocolate ice cream think potential better worse 'required patients prove compliant court ordered treatment might good thing treatment part diversionary program mental health court might want able prove judge taking medications got sick anyway fault i think technology approved may well end role outpatient civil commitment require patients take medications schizophrenia expert william carpenter md interviewed psych news mentioned several concerns technology provide important advances addressing highly prevalent problems patients adhering medications kane told psychiatric news however kane pointed major concerns regarding use technology likely arise information obtained device protected william carpenter professor psychiatry pharmacology university maryland school medicine agreed addition issues privacy carpenter told psychiatric news convincing people already vulnerable paranoia take medication may viewed highly intrusive well potential high cost medicine could present additional challenges carpenter described several questions therapy including best determine candidates ingestible sensor medications additionally said psychiatrists may need consider questions acceptable privacy compromise involuntary commitment device lead fewer person visits clinicians reduce chances integrative treatment early detection relapse carpenter concluded psychiatrists ready innovative approach treating mental illness device successful little compromise patient field embrace point much big brother me